Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, X.
Right arrow Articles by Benedict, W. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, X.
Right arrow Articles by Benedict, W. F.
[Cancer Research 63, 760-765, February 15, 2003]
© 2003 American Association for Cancer Research


Advances in Brief

Adenoviral-mediated Retinoblastoma 94 Produces Rapid Telomere Erosion, Chromosomal Crisis, and Caspase-dependent Apoptosis in Bladder Cancer and Immortalized Human Urothelial Cells but not in Normal Urothelial Cells1

Xinqiao Zhang, Asha S. Multani, Jain-Hua Zhou, Jerry W. Shay, David McConkey, Li Dong, Chang-Soo Kim, Charles J. Rosser, Sen Pathak and William F. Benedict2

Departments of Genitourinary Medical Oncology [X. Z., J-H. Z., L. D., C-S. K., W. F. B.], Cancer Biology [A. S. M., D. M., S. P.], and Urology [C. J. R.], The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, and Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas Texas 75390 [J. W. S.]

Retinoblastoma (RB)94, which lacks the NH2-terminal 112 amino acid residues of the full-length RB protein (RB110), is a more potent tumor and growth suppressor than RB110. In this study, Ad-RB94, but not Ad-RB110, produced marked growth inhibition, cytotoxicity, caspase-dependent apoptosis, and G2-M block in the human RB-negative, telomerase-positive bladder cancer cell line UM-UC14. This effect was completely inhibited by pretreatment with caspase inhibitors (P < 0.0001). Similar results were seen in RB-positive and other RB-negative bladder cancer cell lines. Ad-RB94 produced rapid telomere length shortening and loss of telomere signal, which was associated with polyploidy and chromosomal aberrations (P < 0.001). Ad-RB94, however, showed no cytotoxicity to telomerase-negative human normal urothelium cells but was highly cytotoxic to telomerase-positive human E6 and E7 immortalized urothelial cells (P < 0.0001). In addition, telomerase-negative cells, which maintain their telomere length through an alternative lengthening of telomeres DNA recombination pathway, showed no cytotoxicity to RB94. These results suggest that the induction of rapid telomere erosion and chromosomal crisis by RB94 in telomerase-positive cancer and in telomerase-expressing immortalized human cells is a major factor in its selective and potent tumor suppression and cytotoxic activity. The lack of cytotoxicity to normal cells should also provide a high therapeutic index when used in gene therapy protocols for the treatment of bladder and other cancers.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
K. Araki, S. M. Ahmad, G. Li, D. A. Bray Jr, K. Saito, D. Wang, U. Wirtz, S. Sreedharan, B. W. O'Malley Jr, and D. Li
Retinoblastoma RB94 Enhances Radiation Treatment of Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res., June 1, 2008; 14(11): 3514 - 3519.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. F. Pirollo, A. Rait, Q. Zhou, X.-q. Zhang, J. Zhou, C.-S. Kim, W. F. Benedict, and E. H. Chang
Tumor-Targeting Nanocomplex Delivery of Novel Tumor Suppressor RB94 Chemosensitizes Bladder Carcinoma Cells In vitro and In vivo
Clin. Cancer Res., April 1, 2008; 14(7): 2190 - 2198.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. P. Mitra, R. H. Datar, and R. J. Cote
Molecular Pathways in Invasive Bladder Cancer: New Insights Into Mechanisms, Progression, and Target Identification
J. Clin. Oncol., December 10, 2006; 24(35): 5552 - 5564.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. M. Roig, M. A. Molina, A. Cascante, J. Calbo, N. Carbo, U. Wirtz, S. Sreedharan, C. Fillat, and A. Mazo
Adenovirus-Mediated Retinoblastoma 94 Gene Transfer Induces Human Pancreatic Tumor Regression in a Mouse Xenograft Model
Clin. Cancer Res., February 15, 2004; 10(4): 1454 - 1462.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Xiong, S. Fan, Q. Meng, L. Schramm, C. Wang, B. Bouzahza, J. Zhou, B. Zafonte, I. D. Goldberg, B. R. Haddad, et al.
BRCA1 Inhibition of Telomerase Activity in Cultured Cells
Mol. Cell. Biol., December 1, 2003; 23(23): 8668 - 8690.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. W. Shay
Telomerase Therapeutics: Telomeres Recognized as a DNA Damage Signal: Commentary re: K. Kraemer et al., Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin. Cancer Res., 9: 3794-3800, 2003.
Clin. Cancer Res., September 1, 2003; 9(10): 3521 - 3525.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.